Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.

Tsai SC, Lin SJ, Chen PW, Luo WY, Yeh TH, Wang HW, Chen CJ, Tsai CH.

Blood. 2009 Jul 2;114(1):109-18. doi: 10.1182/blood-2008-12-193375. Epub 2009 May 5.

2.

Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.

Tanner JE, Alfieri C.

Leuk Lymphoma. 1996 May;21(5-6):379-90. Review. Erratum in: Leuk Lymphoma 2001 Nov-Dec;42(6):following 1447.

PMID:
9172802
3.

Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.

Hsu M, Wu SY, Chang SS, Su IJ, Tsai CH, Lai SJ, Shiau AL, Takada K, Chang Y.

J Virol. 2008 Apr;82(7):3679-88. doi: 10.1128/JVI.02301-07. Epub 2008 Jan 30.

4.

Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.

Sharif-Askari E, Fawaz LM, Tran P, Ahmad A, Menezes J.

J Natl Cancer Inst. 2001 Nov 21;93(22):1724-32.

PMID:
11717333
7.

Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.

Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T, Sculley T.

Virology. 1998 Dec 20;252(2):418-30.

9.

Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.

Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H.

J Med Virol. 2001 Jun;64(2):141-8.

PMID:
11360246
10.

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.

Kalla M, Hammerschmidt W.

Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Review.

PMID:
21450364
11.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
12.

Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.

Lai KY, Chou YC, Lin JH, Liu Y, Lin KM, Doong SL, Chen MR, Yeh TH, Lin SJ, Tsai CH.

J Virol. 2015 Jun;89(11):5968-80. doi: 10.1128/JVI.00168-15. Epub 2015 Mar 25.

13.

Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.

Chang Y, Lee HH, Chen YT, Lu J, Wu SY, Chen CW, Takada K, Tsai CH.

J Virol. 2006 Aug;80(15):7748-55.

14.

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.

Xu ZG, Iwatsuki K, Oyama N, Ohtsuka M, Satoh M, Kikuchi S, Akiba H, Kaneko F.

Br J Cancer. 2001 Apr 6;84(7):920-5.

15.

A molecular link between malaria and Epstein-Barr virus reactivation.

Chêne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT.

PLoS Pathog. 2007 Jun;3(6):e80.

16.

Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr Virus infected B cells.

Konforte D, Paige CJ.

Virus Res. 2009 Sep;144(1-2):339-43. doi: 10.1016/j.virusres.2009.05.003. Epub 2009 May 15.

PMID:
19447148
17.
18.

Immune activation suppresses initiation of lytic Epstein-Barr virus infection.

Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.

Cell Microbiol. 2007 Aug;9(8):2055-69. Epub 2007 Apr 5.

PMID:
17419714
20.

EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.

Katsumura KR, Maruo S, Takada K.

J Med Virol. 2012 Mar;84(3):504-10. doi: 10.1002/jmv.23208.

PMID:
22246839

Supplemental Content

Support Center